Logo image of NTHI

NEONC TECHNOLOGIES HOLDINGS (NTHI) Stock Overview

USA - NASDAQ:NTHI - US64051A1016 - Common Stock

12 USD
+0.12 (+1.01%)
Last: 9/24/2025, 8:25:42 PM

NTHI Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap229.92M
Shares19.16M
Float9.08M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.73
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10
IPO03-26 2025-03-26
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


NTHI short term performance overview.The bars show the price performance of NTHI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150 200

NTHI long term performance overview.The bars show the price performance of NTHI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of NTHI is 12 USD. In the past month the price increased by 96.72%.

NEONC TECHNOLOGIES HOLDINGS / NTHI Daily stock chart

NTHI Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 45.93 702.13B
JNJ JOHNSON & JOHNSON 17.67 425.53B
NVO NOVO-NORDISK A/S-SPONS ADR 14.95 261.01B
NVS NOVARTIS AG-SPONSORED ADR 13.9 238.11B
AZN ASTRAZENECA PLC-SPONS ADR 16.97 233.65B
MRK MERCK & CO. INC. 10.35 199.00B
PFE PFIZER INC 7.11 136.96B
SNY SANOFI-ADR 10.4 113.17B
BMY BRISTOL-MYERS SQUIBB CO 6.56 89.89B
GSK GSK PLC-SPON ADR 8.91 80.95B
ZTS ZOETIS INC 22.78 62.79B
TAK TAKEDA PHARMACEUTIC-SP ADR 51.59 47.25B

About NTHI

Company Profile

NTHI logo image NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Calabasas, California. The company went IPO on 2025-03-26. The firm is focused on establishing treatments for intracranial malignancies, such as aggressive cancers located in the brain. The company is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company is developing novel drug delivery methods to be used in combination with novel drug candidates. The firm has two lead products in development: NEO100 and NEO212. NEO100 is a purified form of perillyl acid (POH) which is administered to brain cancer patients via intranasal delivery. NEO212 is a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol. NEO212 is undergoing development towards intranasal application specifically for patients with uncontrolled brain metastases derived from peripheral tumors (lung, breast, skin, and others).

Company Info

NEONC TECHNOLOGIES HOLDINGS

23975 Park Sorrento, Suite 205

Calabasas CALIFORNIA US

Employees: 3

NTHI Company Website

Phone: 13106637831

NEONC TECHNOLOGIES HOLDINGS / NTHI FAQ

What is the stock price of NEONC TECHNOLOGIES HOLDINGS today?

The current stock price of NTHI is 12 USD. The price increased by 1.01% in the last trading session.


What is the ticker symbol for NEONC TECHNOLOGIES HOLDINGS stock?

The exchange symbol of NEONC TECHNOLOGIES HOLDINGS is NTHI and it is listed on the Nasdaq exchange.


On which exchange is NTHI stock listed?

NTHI stock is listed on the Nasdaq exchange.


What is NEONC TECHNOLOGIES HOLDINGS worth?

NEONC TECHNOLOGIES HOLDINGS (NTHI) has a market capitalization of 229.92M USD. This makes NTHI a Micro Cap stock.


How many employees does NEONC TECHNOLOGIES HOLDINGS have?

NEONC TECHNOLOGIES HOLDINGS (NTHI) currently has 3 employees.


What are the support and resistance levels for NEONC TECHNOLOGIES HOLDINGS (NTHI) stock?

NEONC TECHNOLOGIES HOLDINGS (NTHI) has a resistance level at 12.01. Check the full technical report for a detailed analysis of NTHI support and resistance levels.


Should I buy NEONC TECHNOLOGIES HOLDINGS (NTHI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NEONC TECHNOLOGIES HOLDINGS (NTHI) stock pay dividends?

NTHI does not pay a dividend.


When does NEONC TECHNOLOGIES HOLDINGS (NTHI) report earnings?

NEONC TECHNOLOGIES HOLDINGS (NTHI) will report earnings on 2025-11-10.


What is the Price/Earnings (PE) ratio of NEONC TECHNOLOGIES HOLDINGS (NTHI)?

NEONC TECHNOLOGIES HOLDINGS (NTHI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.73).


What is the Short Interest ratio of NEONC TECHNOLOGIES HOLDINGS (NTHI) stock?

The outstanding short interest for NEONC TECHNOLOGIES HOLDINGS (NTHI) is 1.36% of its float. Check the ownership tab for more information on the NTHI short interest.


NTHI Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to NTHI.


Chartmill TA Rating
Chartmill Setup Rating

NTHI Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to NTHI. Both the profitability and financial health of NTHI have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NTHI Financial Highlights

Over the last trailing twelve months NTHI reported a non-GAAP Earnings per Share(EPS) of -2.73. The EPS increased by 20.26% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -591.12%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)20.26%
Revenue 1Y (TTM)17.73%

NTHI Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

NTHI Ownership

Ownership
Inst Owners0.84%
Ins Owners24.95%
Short Float %1.36%
Short Ratio0.48